Salivary biomarkers such as cortisol, melatonin, alpha-amylase, chromogranin A, C-reactive protein, and immunoglobulin A offer a non-invasive method for monitoring stress, sleep quality, and disease severity in patients with atopic dermatitis.
This review highlights the potential of salivary biomarkers as non-invasive tools for monitoring stress, sleep quality, and disease severity in atopic dermatitis patients. The biomarkers include cortisol, melatonin, alpha-amylase, chromogranin A, C-reactive protein, and immunoglobulin A. The paper does not provide quantitative effect sizes or specific clinical thresholds.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Salivary biomarkers such as cortisol, melatonin, alpha-amylase, chromogranin A, C-reactive protein, and immunoglobulin A offer a non-invasive method for monitoring stress, sleep quality, and disease severity in patients with atopic dermatitis. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Salivary biomarkers such as cortisol, melatonin, alpha-amylase, chromogranin A, C-reactive protein, and immunoglobulin A offer a non-invasive method for monitoring stress, sleep quality, and disease severity in patients with atopic dermatitis.
This conclusion is most relevant to: Patients with atopic dermatitis (general population, not specified further)..
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Atopic dermatitis: pathogenesis, immunology, microbiome, and salivary biomarkers. (Frontiers in immunology, 2026) —
How It Works
The proposed biological pathway:
- ▸Atopic dermatitis involves genetic predisposition, immune dysregulation, and environmental factors.
- ▸Skin and gut microbiota imbalances contribute to skin barrier dysfunction.
- ▸Salivary biomarkers reflect neuroendocrine and immune activity.
- ▸These biomarkers can be measured non-invasively to indicate stress, sleep quality, and disease severity.
Who Might Benefit
Evidence fit by population:
- ▸Patients with atopic dermatitis (general population, not specified further).
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸This is a review paper, not an empirical study, so no direct data or effect sizes are provided.
- ▸The abstract does not specify the sensitivity, specificity, or clinical validation of these salivary biomarkers.
- ▸The relationship between salivary biomarkers and sleep quality is not quantified or directly tested.
Frequently Asked Questions
What are the salivary biomarkers mentioned for atopic dermatitis?▼
The biomarkers are cortisol, melatonin, alpha-amylase, chromogranin A, C-reactive protein, and immunoglobulin A.
How can salivary biomarkers help in atopic dermatitis management?▼
They offer a non-invasive method to monitor stress, sleep quality, and disease severity, potentially aiding in earlier diagnosis and better long-term management.
Are these salivary biomarkers validated for clinical use?▼
The abstract does not provide validation data; it only suggests their potential as monitoring tools. Further research is needed.
What is the role of the microbiome in atopic dermatitis?▼
Microbial imbalance in skin and gut contributes to skin barrier dysfunction, which is part of the disease pathogenesis.
References
- 1.Abraityte S, Tamasauskiene L, Gasiuniene E, Jankauskaite L. “Atopic dermatitis: pathogenesis, immunology, microbiome, and salivary biomarkers..” Frontiers in immunology, 2026. PMID: 42591907 DOI: 10.3389/fimmu.2026.1782602